← Leaderboards
Douglas Matthew Smith
Aastrom Biosciences, Inc.
$1,272,161
Attributed
$1,272,161
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,272,161 · 5
By mechanism
R44$755,884 · 1
R43$335,002 · 3
R01$181,275 · 1
Top collaborators
No co-investigators on record.
Most similar at Aastrom Biosciences, Inc.
Same institution · by research overlap
- Kristin L Goltry$2,224,364
Others in their field
Top investigators on “Bioreactors”
- Gordana Vunjak-Novakovic · Tufts University Medford$18,839,009
- Venkata Mangalampalli · Leidos Biomedical Research, Inc.$11,808,611
- Bruce Dale Weintraub · University Of Maryland Baltimore$11,580,107
- Laura E Niklason · Duke University$10,288,273
- Karen K Hirschi · University Of Virginia$10,235,512
- Robert T Tranquillo · University Of Minnesota Twin Cities$9,615,001
Research focus
BioreactorsTumor AntigensMethod DevelopmentDendritic CellsCarcinoembryonal AntigenHuman TissueNeoplasm /Cancer VaccineVaccine DevelopmentAntitumor AntibodyBiotechnologyCytotoxic T LymphocyteClinical ResearchMass Tissue /Cell CultureFlow CytometryCell TransplantationBiomedical AutomationBiomedical Equipment DevelopmentClinical Biomedical EquipmentEvaluation /TestingCytokineHuman SubjectCell DifferentiationCd34 MoleculeBioengineering /Biomedical Engineering
Grant awards (6)
Bioreactor for Enhanced T-cell Based Therapy of Melanoma$124,154
R43 · FY2004 · CA
Dendritic Cell Subset for Enhanced Cancer Vaccine$109,586
R43 · FY2004 · CA
Enhanced Tumor Antigen Priming of Dendritic Cell Vaccine$101,262
R43 · FY2003 · CA
CLINICAL SCALE EXPANSION OF HUMAN DENDRITIC CELLS$421,537
R44 · FY2001 · CA
CLINICAL SCALE EXPANSION OF HUMAN DENDRITIC CELLS$334,347
R44 · FY2000 · CA
OPTIMIZED EXPANSION/TRANSDUCTION OF HEMATOPOIETIC CELLS$181,275
R01 · FY2000 · DK